Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04769960 · ClinicalTrials.gov registry record
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
A clinical trial of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 68
- Enrollment target
- 3
- Study locations
NCT04769960 is a study of Breast Cancer and Breast Neoplasms that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 68 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT04769960, a study of Breast Cancer and Breast Neoplasms, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 68 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to find out whether it is safe to perform MRI scans in people who have breast tissue expanders in place.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI Studies
- BEHAVIORAL Patient Reported Outcomes
Study Locations (3)
New York
- Memorial Sloan Kettering Commack (Consent Only) - Commack
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Bergen (Consent only ) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2026-02-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04769960
The ClinicalTrials.gov registry entry for NCT04769960 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which MRI Studies is the first listed.
NCT04769960 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04769960 about?
NCT04769960 is a clinical study titled "Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy". The purpose of this study is to find out whether it is safe to perform MRI scans in people who have breast tissue expanders in place.
What is the current status of trial NCT04769960?
This trial is currently active not recruiting. The enrollment target is 68 participants. The study started on 2021-02-19. Estimated completion is 2026-02-19.
What conditions does trial NCT04769960 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Breast Adenocarcinoma.
What interventions are being tested in trial NCT04769960?
The interventions under investigation include: MRI Studies (DIAGNOSTIC_TEST), Patient Reported Outcomes (BEHAVIORAL).
Who is sponsoring clinical trial NCT04769960?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04769960 being conducted?
This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.